Pharmacogenetic testing for antipsychotics is a medical test used to examine genetic variations that affect how individuals respond to antipsychotic medications, such as those used to treat mental disorders like schizophrenia and depression. The test involves analyzing a sample of blood or saliva, where specific genes influencing drug metabolism and the body's interaction with medications are studied. This analysis helps doctors understand how a patient will respond to treatment, enabling them to tailor medications and dosages according to individual needs. The results of this test contribute to improving the effectiveness of treatments and reducing risks associated with side effects. By guiding treatment choices based on genetic information, the quality of life for patients suffering from mental disorders can be enhanced.